Training for Men Undergoing Androgen Deprivation Therapy.

Condition(s) studied

Investigational drug(s) / intervention(s)

ADT-train: A new training concept is tested on men with prostate cancer receiving androgen deprivation therapy

Study summary

The goal of this clinical trial is to evaluate the effects of a newly developed training concept on men with prostate cancer undergoing androgen deprivation therapy (ADT).

The main questions it aims to answer are:

* How feasible and safe is the new training concept?
* How efficient is the training concept to counteract side effects caused by ADT?

Researchers will compare the new training concept with usual care to evaluate how efficient the training concept is to counteract the ADT-related side effects.

Participants in the intervention group will perform the new training concept twice weekly for 12 weeks. Participants in the control group will only receive usual care. All participants will visit the laboratory at baseline and after 6 and 12 weeks to measure the primary and secondary outcomes.

Eligibility

Primary outcome measure(s)

• Aerobic fitness — Baseline and after 6 and 12 weeks
  VO2peak (ml/kg/min); incremental ramp test on a cycle ergometer
• Maximal leg strength — Baseline and after 6 and 12 weeks
  Isometric squat test (N) measured on force plates

Trial sites (1)

More The Swedish School of Sport and Health Sciences trials in Sweden

Other trials for the same condition